KR100920125B1 - 양성 전립선 비대증 치료를 위한 피라졸로피리미디논화합물 및 알파 아드레날린성 수용체 길항제를 함유하는약제학적 배합물 - Google Patents
양성 전립선 비대증 치료를 위한 피라졸로피리미디논화합물 및 알파 아드레날린성 수용체 길항제를 함유하는약제학적 배합물Info
- Publication number
- KR100920125B1 KR100920125B1 KR1020080017768A KR20080017768A KR100920125B1 KR 100920125 B1 KR100920125 B1 KR 100920125B1 KR 1020080017768 A KR1020080017768 A KR 1020080017768A KR 20080017768 A KR20080017768 A KR 20080017768A KR 100920125 B1 KR100920125 B1 KR 100920125B1
- Authority
- KR
- South Korea
- Prior art keywords
- treatment
- prostatic hyperplasia
- receptor antagonist
- urinary tract
- lower urinary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
- 양성 전립선 비대증 및 이와 관련되는 하부요로증상의 예방 및 치료용으로 동시 투여하기 위한 배합물로서, 하기 화학식 1의 피라졸로피리미디논 화합물 및 (R)-5-(2-(2-(2-에톡시페녹시)에틸아미노)프로필)-2-메톡시벤젠술폰아미드 또는 1-(3-하이드록시프로필)-5-[(2R)-({2-[2-[2-(2,2,2-트리플루오로에톡시)페녹시]에틸}아미노)프로필]인돌린-7-카르복사미드 중에서 선택되는 알파 아드레날린성 수용체 길항제를 포함함을 특징으로 하는 양성 전립선 비대증(Benign Prostatic Hyperplasia, BPH) 및 이와 관련되는 하부요로증상(Lower Urinary Tract Symptoms, LUTS)의 예방 및 치료용 조성물.<화학식 1>
- 제 1 항에 있어서, 알파 아드레날린성 수용체 길항제는 (R)-5-(2-(2-(2-에톡시페녹시)에틸아미노)프로필)-2-메톡시벤젠술폰아미드인 것을 특징으로 하는 양성 전립선 비대증 및 이와 관련되는 하부요로증상의 예방 및 치료용 조성물.
- 제 1 항에 있어서, 알파 아드레날린성 수용체 길항제는 1-(3-하이드록시프로필)-5-[(2R)-({2-[2-[2-(2,2,2-트리플루오로에톡시)페녹시]에틸}아미노)프로필]인돌린-7-카르복사미드인 것을 특징으로 하는 양성 전립선 비대증 및 이와 관련되는 하부요로증상의 예방 및 치료용 조성물.
- 삭제
- 삭제
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010115647/15A RU2010115647A (ru) | 2007-10-02 | 2008-09-24 | Композиция и способ лечения или профилактики доброкачественной гиперплазии предстательной железы и симптомов со стороны нижних отделов мочевыводящих путей |
US12/680,777 US20100210668A1 (en) | 2007-10-02 | 2008-09-24 | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms |
EP08835325A EP2192903A4 (en) | 2007-10-02 | 2008-09-24 | COMPOSITION AND METHOD OF TREATMENT OR METHOD PREVENTING SYMPTOMS BENIGNER PROSTATE HYPERPLASIA AND LOWER HARN |
CN200880110056A CN101815520A (zh) | 2007-10-02 | 2008-09-24 | 治疗或预防良性前列腺增生和下尿路症状的组合物和方法 |
CA2701844A CA2701844A1 (en) | 2007-10-02 | 2008-09-24 | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms |
JP2010527878A JP2010540621A (ja) | 2007-10-02 | 2008-09-24 | 良性前立腺肥大症および下部尿路症状の治療または予防用組成物、およびその治療または予防方法 |
PCT/KR2008/005669 WO2009045019A2 (en) | 2007-10-02 | 2008-09-24 | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms |
AU2008307905A AU2008307905A1 (en) | 2007-10-02 | 2008-09-24 | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms |
MX2010003193A MX2010003193A (es) | 2007-10-02 | 2008-09-24 | Composicion y metodo para el tratamiento o prevencion de hiperplasia prostatica benigna y sintomas del tracto urinario inferior. |
ARP080104272A AR068595A1 (es) | 2007-10-02 | 2008-09-30 | Composicion y metodo para el tratamiento o la prevencion de hiperplasia prostatica benigna y sintomas del tracto urinario inferior |
TW097137487A TW200918072A (en) | 2007-10-02 | 2008-09-30 | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms |
IL204694A IL204694A0 (en) | 2007-10-02 | 2010-03-23 | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms |
ZA2010/02470A ZA201002470B (en) | 2007-10-02 | 2010-04-08 | Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms |
CO10051733A CO6270327A2 (es) | 2007-10-02 | 2010-04-30 | Composicion que comprende un compuesto pirazolopirimidinona y el antagonista del receptor adrenergico alfa |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20070099016 | 2007-10-02 | ||
KR1020070099016 | 2007-10-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090034266A KR20090034266A (ko) | 2009-04-07 |
KR100920125B1 true KR100920125B1 (ko) | 2009-10-01 |
Family
ID=40760274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080017768A KR100920125B1 (ko) | 2007-10-02 | 2008-02-27 | 양성 전립선 비대증 치료를 위한 피라졸로피리미디논화합물 및 알파 아드레날린성 수용체 길항제를 함유하는약제학적 배합물 |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR100920125B1 (ko) |
SA (1) | SA08290696B1 (ko) |
UA (1) | UA95028C2 (ko) |
ZA (1) | ZA201002470B (ko) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100353014B1 (ko) * | 1998-11-11 | 2002-09-18 | 동아제약 주식회사 | 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물 |
-
2008
- 2008-02-27 KR KR1020080017768A patent/KR100920125B1/ko active IP Right Grant
- 2008-09-24 UA UAA201004418A patent/UA95028C2/ru unknown
- 2008-11-01 SA SA08290696A patent/SA08290696B1/ar unknown
-
2010
- 2010-04-08 ZA ZA2010/02470A patent/ZA201002470B/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100353014B1 (ko) * | 1998-11-11 | 2002-09-18 | 동아제약 주식회사 | 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물 |
Also Published As
Publication number | Publication date |
---|---|
UA95028C2 (ru) | 2011-06-25 |
ZA201002470B (en) | 2011-06-29 |
KR20090034266A (ko) | 2009-04-07 |
SA08290696B1 (ar) | 2013-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100406011C (zh) | 含乙酸酰基苯胺衍生物作为活性成分的膀胱活动过度的治疗药物 | |
US20060258712A1 (en) | Methods for modulating bladder function | |
US8247417B2 (en) | Methods of treatment of chronic pain using eszopiclone | |
JP7069253B2 (ja) | 統合失調症を治療するための2-((1-(2(4-フルオロフェニル)-2-オキソエチル)ピペリジン-4-イル)メチル)イソインドリン-1-オン | |
TW200524611A (en) | Methods of preventing and reducing the severity of stress-associated conditions | |
KR20080076961A (ko) | Pde5 억제제 및 무스카린성 길항제를 포함하는luts의 치료를 위한 약제학적 조합물 | |
ES2532210T3 (es) | Métodos para el tratamiento concomitante de teofilina y febuxostat | |
JP2009526821A (ja) | 注意欠陥多動性障害治療用の新規な医薬組成物 | |
KR20050042154A (ko) | 통증의 치료에 사용하기 위한 알파-2-델타 리간드와 pdev 억제제의 상승작용 조합물 | |
KR20110062943A (ko) | 퀴나졸린 유도체를 유효성분으로 하는 전립선 비대증 예방 또는 치료제 | |
JP2008508264A (ja) | N−ヒドロキシ−4−{5−[4−(5−イソプロピル−2−メチル−1,3−チアゾール−4−イル)フェノキシ]ペントキシ}メンズアミジン2メタンスルホン酸塩 | |
NZ570492A (en) | Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of excess salivation or drooling | |
AU2018309372A1 (en) | Methods of treating behavior alterations | |
KR101471585B1 (ko) | 트라마돌 및 콕시브의 공결정 | |
JP2023145479A (ja) | アンドロゲン除去療法随伴症状の治療 | |
JP2009520806A (ja) | PDE−5阻害薬と5−α還元酵素阻害薬の医薬組合せ | |
IL293661A (en) | Methods for treating the corona virus | |
KR100920125B1 (ko) | 양성 전립선 비대증 치료를 위한 피라졸로피리미디논화합물 및 알파 아드레날린성 수용체 길항제를 함유하는약제학적 배합물 | |
US20070093493A1 (en) | Treatment of benign prostatic hypertrophy and lower urinary tract symptoms | |
JP2022523499A (ja) | チアゾリン抗痛覚過敏薬を用いて疼痛を処置する方法 | |
EP1676573A1 (en) | Phamaceutical composition comprising a 2,5-dihydroxybenzenesulfonic-compound, a potassium ion channel modulator and a phosphodiesterase type 5 inhibitor | |
JP2010540621A (ja) | 良性前立腺肥大症および下部尿路症状の治療または予防用組成物、およびその治療または予防方法 | |
CA2697137A1 (en) | Pharmaceutical composition for amelioration of lower urinary tract symptoms associated with prostatomegaly | |
KR101002490B1 (ko) | 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물 | |
KR100792126B1 (ko) | 피라졸로피리미디논 화합물을 유효성분으로 함유하는전립선 비대증 예방 및 치료제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121231 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20131226 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20141211 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20151230 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20161222 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20181217 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20191126 Year of fee payment: 12 |